학술논문
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders April 2023 72
Subject
Language
ISSN
2211-0348